CVS Health Corporation (CVS)
$
72.14
+0.21 (0.29%)
Key metrics
Financial statements
Free cash flow per share
3.7757
Market cap
91.2 Billion
Price to sales ratio
0.2360
Debt to equity
1.0691
Current ratio
0.8034
Income quality
1.6840
Average inventory
17.4 Billion
ROE
0.0595
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
CVS Health Corporation provides a comprehensive range of health services across the United States, demonstrating its commitment to meet the diverse needs of its clientele. The company’s Health Care Benefits segment offers a variety of health insurance products, including traditional, voluntary, and consumer-directed options, aimed at employer groups, individuals, college students, part-time workers, and various other organizations such as health plans and governmental units. With a net income ratio of 0.01 reflecting its profitability margin, CVS Health showcases its financial strength through an operating income of $8,516,000,000.00 indicative of its core operational earnings. The company earned an interest income of $0.00 showcasing its financial investments and ability to generate revenue outside its primary services. Additionally, the gross profit stands at $51,401,000,000.00 highlighting the effectiveness of its core operations. In its Pharmacy Services segment, CVS Health offers pharmacy benefit management solutions, including plan design, formulary management, and specialty pharmacy services, catering to a wide range of clients from employers to individuals. This segment plays a crucial role in managing medication needs and delivering tailored health care solutions. As of December 31, 2021, CVS Health operated approximately 9,900 retail locations and 1,200 MinuteClinic facilities, further affirming its extensive presence in the health care market. Within the financial landscape, CVS Health's stock is identified with the symbol 'CVS', attracting a variety of investors. The stock is affordable at $64.36 suitable for budget-conscious investors, while its high average trading volume of 7,397,036.00 indicates strong liquidity. With a large market capitalization of $91,497,326,200.00 the company stands as a dominant player in the health services industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, CVS Health is instrumental in driving innovation and growth, shaping the future of health care delivery and access. This strategic positioning not only enhances its market influence but also ensures it remains a pivotal force within the evolving health care industry.
Investing in CVS Health Corporation (CVS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict CVS Health Corporation stock to fluctuate between $43.56 (low) and $72.51 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-08-29, CVS Health Corporation's market cap is $91,497,326,200, based on 1,268,330,000 outstanding shares.
Compared to Eli Lilly & Co., CVS Health Corporation has a Lower Market-Cap, indicating a difference in performance.
CVS Health Corporation pays dividends. The current dividend yield is 4.35%, with a payout of $0.67 per share.
To buy CVS Health Corporation (CVS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CVS. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
CVS Health Corporation's last stock split was 2:1 on 2005-06-07.
Revenue: $372,809,000,000 | EPS: $3.66 | Growth: -43.61%.
Visit https://www.cvshealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $111.25 (2022-02-08) | All-time low: $43.56 (2024-12-23).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.
youtube.com
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
youtube.com
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
zacks.com
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
zacks.com
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.
reuters.com
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness.
zacks.com
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
seekingalpha.com
CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive improved YoY margins despite the rising medical costs. This is on top of the somewhat stable performance metrics observed in the PBM and pharmacy end markets, as the management confidently raises the FY2025 adj EPS guidance. These directly contrast the massive pessimism observed in CVS' healthcare peers, where CEO is being replaced and FY2025 guidance has been cut/ suspended.
seekingalpha.com
Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the sector's business model remains intact despite recent headwinds. CVS has emerged as a top performer in 2025, with strong revenue growth and raised guidance, outpacing struggling peers like UnitedHealth. The sector faces ongoing uncertainties—rising costs, regulatory scrutiny, and budget cuts—but long-term healthcare spending trends remain favorable.
zacks.com
CVS Health commits $20B to build an open health platform, joining tech giants in a push to streamline patient care access nationwide.
See all news